4//SEC Filing
Aradhye Shreeram 4
Accession 0001399529-21-000149
CIK 0001399529other
Filed
Sep 16, 8:00 PM ET
Accepted
Sep 17, 6:48 PM ET
Size
8.7 KB
Accession
0001399529-21-000149
Insider Transaction Report
Form 4
Aradhye Shreeram
EVP & Chief Medical Officer
Transactions
- Sale
Common Stock
2021-09-17$21.47/sh−2,056$44,142→ 4,969 total - Exercise/Conversion
Common Stock
2021-09-15+7,025→ 7,025 total - Exercise/Conversion
Restricted Stock Units
2021-09-15−7,025→ 21,075 total→ Common Stock (7,025 underlying)
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents the contingent right to receive one share of the Issuer's Common Stock.
- [F2]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the RSUs and does not represent a discretionary trade by the Reporting Person.
- [F3]Represents RSUs that vest over a period of four years, with 25% of the RSUs vesting on each of the first, second, third and fourth anniversaries of September 15, 2020, subject in each case to the Reporting Person's continued employment or service with the Issuer through the applicable vesting date.
Documents
Issuer
Dicerna Pharmaceuticals Inc
CIK 0001399529
Entity typeother
Related Parties
1- filerCIK 0001778372
Filing Metadata
- Form type
- 4
- Filed
- Sep 16, 8:00 PM ET
- Accepted
- Sep 17, 6:48 PM ET
- Size
- 8.7 KB